CD163 and COVID-19: Other work demonstrating infection of lung macrophages in SARS-CoV-2 patients has found that CD163 + LGMN+ exposed to SARS-COV-2 promote fibrosis and Acute Respiratory Distress Syndrome (ARDS) in COVID-19 [48].